Abstract:Objective Factor VII deficiency is one of the most common Rare Bleeding Disorders (RBDs). Its phenotype is highly variable, ranging from asymptomatic to spontaneous bleeding. Cardiac surgery is likely one of the most complex scenarios for this type of patients, where, according to limited literature, maintaining factor VIIa >20% is recommended. In this context, it is important to optimize the patient in the perioperative period, as well as establish an individualized anesthetic plan in order to minimize the risk of bleeding and guide our transfusion decisions according to targets. Design and method We present the case of a 40-year-old male patient with a history of hepatitis infection, diagnosed with subacute endocarditis and awaiting surgery. Preoperative tests during preanesthetic assessment revealed an incidental coagulation abnormality, with an INR of 2.5 uncorrected by vitamin K and plasma. Factor VIIa levels were requested, confirming a severe factor VIIa deficiency (15%).We decided, in collaboration with Cardiac Surgery and Hematology, to closely monitoring coagulation using viscoelastic tests (ROTEM®) and to reserve recombinant factor VII for uncontrollable bleeding situations, due to its high thrombotic risk. Thirty minutes before surgery, a CTextem of 92s was detected, and we transfused 2 units of fresh frozen plasma.In the operating room, we placed two large-caliber peripheral lines and a high-flow central line. Intraoperative advanced monitoring during cardiac surgery was performed, including: invasive blood pressure, conventional pulse oximetry, electrocardiography, BIS®, INVOS® (cerebral oximetry) and transesophageal ultrasound.Initially, we administered 1 gram of tranexamic acid intravenous bolus followed by continuous infusion (1mg/kg/h) according to the local protocol. Heparin was also administered to achieve an acting clotting time of 480s. The valvular defect was repaired without incidents. Before coming off cardiopulmonary bypass, we repeat ROTEM® detecting a CTextem of 94s and CTintem of 2058s. (Image1).Then, we transfused 1 unit of fresh frozen plasma, 500 IU of prothrombin complex, and 300mg of protamine. Although CTintem was corrected, CTextem remained prolonged. Finally, we transfused 3 doses of recombinant factor VII (3mg) as a result of evident uncontrollable bleeding despite surgical efforts, then viscoelastic test was repeated. Eventually, the bleeding was controlled, and the CTextem corrected (52s). (Image2).The patient was transferred to the intensive care unit (ICU) intubated for postoperative control. Extubation occurred 6 hours later without incidents. During his stay in the ICU, both bleeding and the potential thrombotic event were closely monitored. After 3 days without significant events, the patient was discharged to the Cardiac Surgery ward. Results and conclusions The case presented illustrates how cardiac surgery can be safely performed in a patient with Factor VII deficiency under thromboelastography-guidance. Factors such as baseline factor activity, bleeding history, and the type of surgery are crucial in deciding the best management approach. A team effort involving cardiologists, anesthesiologists, and hematologists is key to plan the procedure. The monitoring of coagulation with viscoelastic tests can be used as a guide for safely performing the transfusion of blood products. Due to the rarity of Rare Bleeding Disorders, collecting case reports is essential to improve our understanding of RBD management.

Rare bleeding disorders: Real-world data from a Spanish tertiary hospital

Molecular and Clinical Profile of Rare Bleeding Disorders: A Single-center Retrospective Study

Rare bleeding disorders: Advances in management

The History of Rare Bleeding Disorders

Clinical and Economic Consequences of a First Major Bleeding Event in Patients Treated with Direct Factor Xa Inhibitors in Spain: A Long-Term Observational Study

Successful Laparoscopic Common Bile Duct Exploration in A Patient with Factor V Deficiency, A Case Report and Review of Literature

Characteristics Associated with Annual Bleeding Frequency among Hemophilia Patients in the United States

Monitoring coagulation with thromboelastography in a patient with factor VII deficiency undergoing cardiac surgery: A diagnostic and therapeutic challenge.

Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database

Hereditary coagulation factor XI deficiency: a rare or neglected disease? Results from a retrospective, single-centre cohort in northern Italy

Real world management of individuals with severe FXI deficiency and its impact on clinical outcomes: Experience from a haemophilia treatment centre

Excellent Clinical and Pharmacokinetic Real-World Experience after Switching to Rurioctocog ALFA Pegol

Haemoglobinopathies and other rare anemias in Spain: ten years of a nationwide registry (REHem-AR)

Assessment of rare bleeding disorders in adolescents with heavy menstrual bleeding

Switching hemophilia A patients to rVIII-SingleChain: The Iberian experience

A Single-Center Study of Patients with Isolated Acquired Clotting Factors Deficiency: Clinical Features, Treatments and Prognosis

Global epidemiology of factor XI deficiency: A targeted review of the literature and foundation reports

Joint deficiency of coagulation factors VII and IX: a case report

Challenges in the diagnosis and management of patients with rare coagulation disorders in Lebanon and consequences of a social and economic crisis

Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders

Understanding the Impact of Aberrant Splicing in Coagulation Factor V Deficiency